BioCryst Pharmaceuticals, Inc.
BCRX
$8.73
$0.789.81%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 295.09M | 320.85M | 330.01M | 272.03M | 336.55M |
| Total Receivables | 93.39M | 79.07M | 72.46M | 68.76M | 60.59M |
| Inventory | 6.87M | 8.09M | 7.56M | 4.45M | 29.78M |
| Prepaid Expenses | 14.33M | 13.75M | 16.28M | 16.43M | 18.38M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 291.00K | 210.00K | 813.00K | 1.80M | 1.80M |
| Total Current Assets | 409.98M | 421.97M | 427.13M | 363.46M | 447.10M |
|
|
|||||
| Total Current Assets | 409.98M | 421.97M | 427.13M | 363.46M | 447.10M |
| Net Property, Plant & Equipment | 19.58M | 19.79M | 19.63M | 19.85M | 20.71M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 29.95M | 28.34M | 25.07M | 24.79M | 79.00K |
| Total Assets | 480.05M | 490.42M | 491.25M | 472.42M | 467.89M |
|
|
|||||
| Total Accounts Payable | 10.05M | 11.64M | 13.48M | 7.79M | 11.91M |
| Total Accrued Expenses | 92.64M | 113.29M | 104.20M | 89.60M | 79.25M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 37.17M | 35.45M | 35.89M | 31.68M | 28.76M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 139.86M | 160.38M | 153.57M | 129.07M | 119.92M |
|
|
|||||
| Total Current Liabilities | 139.86M | 160.38M | 153.57M | 129.07M | 119.92M |
| Long-Term Debt | 782.03M | 795.92M | 796.11M | 808.48M | 813.04M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 10.09M | 10.05M | 10.14M | 10.48M | 11.10M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 931.97M | 966.35M | 959.82M | 948.03M | 944.06M |
|
|
|||||
| Common Stock & APIC | 1.32B | 1.29B | 1.27B | 1.25B | 1.24B |
| Retained Earnings | -1.77B | -1.77B | -1.74B | -1.73B | -1.72B |
| Treasury Stock & Other | 1.13M | 921.00K | 2.29M | 557.00K | 771.00K |
| Total Common Equity | -451.93M | -475.93M | -468.56M | -475.61M | -476.17M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -451.93M | -475.93M | -468.56M | -475.61M | -476.17M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -451.93M | -475.93M | -468.56M | -475.61M | -476.17M |
|
|
|||||